Haifeng Xu

2PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 14, 2025
Protein Profiles Predict Treatment Responses to the PI3K Inhibitor Umbralisib in Patients with Chronic Lymphocytic Leukemia.

Yanping Yin, Haifeng Xu, Liye He

|Aug 23, 2022
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia.

Yanping Yin, Paschalis Athanasiadis, Linda Karlsen

Pageof 1